Nuvilex's Subsidiary Files International Patent for All-Natural Flu Virus Treatment

Published: Jan 15, 2013

SILVER SPRING, Md., Jan. 15, 2013 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing natural products and cell and gene therapy solutions for the treatment of human diseases, announced today its subsidiary, KnockOut Technologies, Ltd., has filed a patent in Thailand for all-natural product formulations and their potential use in preventing and treating infections caused by influenza viruses.

Back to news